Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old.
In: Scientific Reports, Jg. 13 (2023-03-29), Heft 1, S. 1-9
Online
academicJournal
Zugriff:
Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (i.e., LAI-PrEP) was approved by the U.S. FDA in 2021. We sought to explore LAI-PrEP decision-making among a nationwide sample of young sexual minority men (YSMM) 17–24 years old. In 2020, HIV-negative/unknown YSMM (n = 41) who met CDC criteria for PrEP were recruited online to participate in synchronous online focus groups eliciting preferences and opinions about LAI-PrEP, as well as the impact of a potential self-administered option. Data were analyzed using inductive and deductive thematic analysis with constant comparison. Preferences and decision-making about LAI-PrEP varied widely among YSMM, with participants frequently comparing LAI-PrEP to oral PrEP regimens. We identified five key themes related to LAI-PrEP decision-making including concerns about adherence to PrEP dosing and clinic appointments, awareness and knowledge of PrEP safety and efficacy data, comfort with needles, minimizing PrEP stigma, and considerations of self-administration. YSMM acknowledged more PrEP options as beneficial to supporting uptake and persistence. [ABSTRACT FROM AUTHOR]
Titel: |
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old.
|
---|---|
Autor/in / Beteiligte Person: | John, Steven A. ; Zapata, Juan P. ; Dang, Madeline ; Pleuhs, Benedikt ; O'Neil, Andrew ; Hirshfield, Sabina ; Walsh, Jennifer L. ; Petroll, Andrew E. ; Quinn, Katherine G. |
Link: | |
Zeitschrift: | Scientific Reports, Jg. 13 (2023-03-29), Heft 1, S. 1-9 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 2045-2322 (print) |
DOI: | 10.1038/s41598-023-32014-8 |
Schlagwort: |
|
Sonstiges: |
|